Use of rituximab in SARS-CoV-2-positive renal transplant recipient with EBV reactivation and probable haemophagocytic lymphohistiocytosis.
Saved in:
| Title: | Use of rituximab in SARS-CoV-2-positive renal transplant recipient with EBV reactivation and probable haemophagocytic lymphohistiocytosis. |
|---|---|
| Authors: | Chan D; Department of Clinical Nephrology and Transplantation, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Department of Haematology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Trust, Cambridge, UK., Karimi S; Department of Clinical Nephrology and Transplantation, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Follows G; Department of Haematology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Trust, Cambridge, UK., Torpey N; Department of Clinical Nephrology and Transplantation, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Suchanek O; Department of Clinical Nephrology and Transplantation, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. ondrej.suchanek@addenbrookes.nhs.uk. |
| Source: | CEN case reports [CEN Case Rep] 2023 Feb; Vol. 12 (1), pp. 27-31. Date of Electronic Publication: 2022 Jun 22. |
| Publication Type: | Case Reports; Review; Journal Article |
| Journal Info: | Publisher: Springer Japan Country of Publication: Japan NLM ID: 101636244 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2192-4449 (Electronic) Linking ISSN: 21924449 NLM ISO Abbreviation: CEN Case Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35729310 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Use of rituximab in SARS-CoV-2-positive renal transplant recipient with EBV reactivation and probable haemophagocytic lymphohistiocytosis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Chan+D%22">Chan D</searchLink>; Department of Clinical Nephrology and Transplantation, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Department of Haematology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Trust, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Karimi+S%22">Karimi S</searchLink>; Department of Clinical Nephrology and Transplantation, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Follows+G%22">Follows G</searchLink>; Department of Haematology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Trust, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Torpey+N%22">Torpey N</searchLink>; Department of Clinical Nephrology and Transplantation, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Suchanek+O%22">Suchanek O</searchLink>; Department of Clinical Nephrology and Transplantation, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. ondrej.suchanek@addenbrookes.nhs.uk. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101636244%22">CEN case reports</searchLink> [CEN Case Rep] 2023 Feb; Vol. 12 (1), pp. 27-31. <i>Date of Electronic Publication: </i>2022 Jun 22. – Name: TypePub Label: Publication Type Group: TypPub Data: Case Reports; Review; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Japan%22">Springer Japan </searchLink><i>Country of Publication: </i>Japan <i>NLM ID: </i>101636244 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2192-4449 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221924449%22">21924449 </searchLink><i>NLM ISO Abbreviation: </i>CEN Case Rep <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35729310 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s13730-022-00711-4 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 27 Titles: – TitleFull: Use of rituximab in SARS-CoV-2-positive renal transplant recipient with EBV reactivation and probable haemophagocytic lymphohistiocytosis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chan D – PersonEntity: Name: NameFull: Karimi S – PersonEntity: Name: NameFull: Follows G – PersonEntity: Name: NameFull: Torpey N – PersonEntity: Name: NameFull: Suchanek O IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2023 Feb Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 2192-4449 Numbering: – Type: volume Value: 12 – Type: issue Value: 1 Titles: – TitleFull: CEN case reports Type: main |
| ResultId | 1 |